• Users Online: 155
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 


 
 Table of Contents  
EDITORIAL
Year : 2019  |  Volume : 11  |  Issue : 1  |  Page : 1-2

Ibnosina Journal of Medicine and Biomedical Sciences steps into the second decade of life


1 Department of Surgery, Division of Transplantation Surgery, The Ohio State University Wexner Medical Center, Comprehensive Transplant Center, Columbus, OH, USA
2 Endocrinology Division, Institute of Medicine, Sheikh Khalifa Medical City, Abu Dhabi; Department of Medicine, Dubai Medical College, Dubai, UAE

Date of Submission18-Oct-2018
Date of Decision04-Jan-2019
Date of Acceptance04-Jan-2019
Date of Web Publication26-Feb-2019

Correspondence Address:
Prof. Elmahdi A Elkhammas
Department of Surgery, Division of Transplantation Surgery, The Ohio State University Wexner Medical Center, Comprehensive Transplant Center, Columbus, OH
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmbs.ijmbs_77_18

Rights and Permissions

How to cite this article:
Elkhammas EA, Beshyah SA. Ibnosina Journal of Medicine and Biomedical Sciences steps into the second decade of life. Ibnosina J Med Biomed Sci 2019;11:1-2

How to cite this URL:
Elkhammas EA, Beshyah SA. Ibnosina Journal of Medicine and Biomedical Sciences steps into the second decade of life. Ibnosina J Med Biomed Sci [serial online] 2019 [cited 2019 Nov 20];11:1-2. Available from: http://www.ijmbs.org/text.asp?2019/11/1/1/253076



The present issue of Ibnosina Journal of Medicine and Biomedical Sciences (IJMBS) is the 58th issue of the journal and is the first issue in its second decade of life. Over the first decade, IJMBS sustained an uninterrupted flow of issues on or after a couple of days from their expected day of release. The editors observed a strict adherence to the peer-review process as the accepted gold standard basis for quality and scholarly status, with the genuine open access being fully freely accessible to authors and readers. So far, we have kept our promise that we pledged in our issue in 2009.[1]

We are cognizant of the common challenges facing emerging journals. These journals are being squeezed between two different forces that threaten their mere existence. The vicious attack from predatory publishers, with huge numbers of journals and aggressive marketing strategies, makes the true open journals struggle to distinguish themselves from the flood of predatory, nonpeer ones that send invitations and reminders on a daily basis.[2] The situation is worsened by the low awareness of young and aspiring researchers of this plague.[3] Furthermore, the drivers of physicians to seek international recognition drain flow of submissions from the regions counted by emerging journals as their constituency.[4] Hence, we cannot blame young authors who may not choose to submit to genuine open-access journals out of fear of falling into the predatory trap. Also, we cannot blame new reviewers who may ignore requests to review from an emerging journal not known to them. The other major challenge comes from the clones of open-access journals created by international publishers building on their visibility, experience, and publishing resources. Nowadays, it is almost the rule rather than the exception that a manuscript submitted to an international journal gets referred to a sister open-access journal with the usual financial implications. Consequently, the mere sustaining of existence under these circumstances should be counted as a success.[5]

Two years ago, the journal was associated with an international publisher with vast experience in medical publishing (Medknow), and a new editorial board took over from the founding team.[6] The new website is more friendly to browsing readers and monitoring assessors as one can see the number of readers viewing and downloading of individual articles. In addition, all articles now have a unique DOI. We continue to attract interests of our readership by publishing relevant original articles and opinions.[7] Our recent editorials on predatory publishing and fake academia were the first to address the issue in Middle-East region.[2],[8] We also continue to capture the interest of our primary target readers by publishing ethnically relevant articles addressing clinical practice and research in developing regions.[2],[8] Some articles have reached or exceeded 1000 viewers. Several articles were cited in established journals 10–20 times, and a single article was cited over 75 times according to the Google Scholar. The increasing number of citations is illustrated in [Figure 1]. In total there was 885 citations since 2012. Its overall h-index is 13 and i10-index 21.[9]
Figure 1: Citation of IJMBS articles detected in Google Scholar search database

Click here to view


The most common question editors receive in public and private circles is: when will you be on PubMed index? Normally, journals take between 3 to 5 years before they get indexed by PubMed. The period may even be longer for emerging journals despite sustaining long and uninterrupted flow of production. When we applied to be indexed in 2015, although the final mark of the appraisal fell short of the required score for affirmative recommendation for IJMBS to be indexed, there were many positive comments on the niche of the journal that make us optimistic in future applications. We have implemented all the recommendations of the Medline listing assessors. All articles have mandatory sets of disclosures that cover author contributions, conflicts of interest, any source of funding, and explicit statement of compliance with ethical principles and specifically detailing the source of ethical approval and nature of consent or the lack thereof. These disclosures are checked before the articles are considered by editors and reviewers over and above the commitments to the other ICMJE recommendations.[10],[11] We await in hope the next round of PubMed/PMC indexation review.

Finally, the editorial board has agreed changing the frequency of publication from bimonthly to quarterly from January 2019 onward [Table 1]. This may mean greater proportion of original articles than review articles. As IJMBS steps into the second decade of its life, we reaffirm our commitments to the scholarly publishing principles and practices and to the genuine open-access movement[12] We greatly appreciate your support in all capacities: readers, authors, and reviewers.
Table 1: The new issue plan adopted from January 2019 onward

Click here to view


Author contribution

Equal.

Conflicts of interest

There are no conflicts of interest.

Funding and sponsorship

None.

Compliance with ethical principles

Not required.



 
  References Top

1.
Elkhammas E. New product of Ibnosina Medical Association. Ibnosina J Med Biomed Sci 2009;1:44-5.  Back to cited text no. 1
  [Full text]  
2.
Beshyah SA. Predatory publishing: A wake-up call for editors and authors in the Middle East and Africa. Ibnosina J Med Biomed Sci 2017;9:123-5.  Back to cited text no. 2
  [Full text]  
3.
Beshyah SA, Hajjaji IM, Elbarsha AW. Awareness of predatory journals among physicians from Africa and the Middle East: An exploratory survey. Ibnosina J Med Biomed Sci 2018:136-40.  Back to cited text no. 3
  [Full text]  
4.
Beshyah SA. Authors' selection of target journals and their attitude to emerging journals: A survey from two developing regions. Sultan Qaboos Univ Med J. [In press].  Back to cited text no. 4
    
5.
Beshyah SA, Elkhammas E. Manuscript peer review for emerging journals: Where we go from here? Ibnosina J Med Biomed Sci 2015;7:155-7.  Back to cited text no. 5
  [Full text]  
6.
Elkhammas E, Beshyah SA. Ibnosina Journal of Medicine and Biomedical Sciences: Thanks to the founding editorial board (2009-2016) and welcome to the new editorial board (2017-2020). Ibnosina J Med Biomed Sci 2017;9:96-8.  Back to cited text no. 6
  [Full text]  
7.
Elkhammas E, Beshyah SA. Ibnosina journal of medicine and biomedical sciences moves house but maintains same editorial philosophy and publishing strategy. Ibnosina J Med Biomed Sci 2017;9:1-2.  Back to cited text no. 7
  [Full text]  
8.
Beshyah SA. Fake academia and bogus conferences are on the rise in the Middle East: Time to act. Ibnosina J Med Biomed Sci 2017;9:147-9.  Back to cited text no. 8
  [Full text]  
9.
Ibnosina Journal of Medicine and Biomedical Sciences on Google Scholar. Available from: https://scholar.google.com/citations?user=Kb1U8cAAAAAJ&hl=en&authuser=19. [Last accessed on 2018 Jan 18].  Back to cited text no. 9
    
10.
Beshyah SA, Aburawi EH, Alshammakhi N, Elkhammas EA. Why should you publish in Ibnosina Journal of Medicine and Biomedical Sciences? Ibnosina J Med Biomed Sci 2017;9:99-100.  Back to cited text no. 10
  [Full text]  
11.
Beshyah SA, Elkhammas EA. The relevance of the international committee of medical journal editors recommendations to emerging medical journalism. Ibnosina J Med Biomed Sci 2019;11:1-2.  Back to cited text no. 11
  [Full text]  
12.
Beshyah SA, Elkhammas EA. The relevance of the international committee of medical journal editors recommendations to emerging journals. Ibnosina J Med Biomed Sci 2019;11:3-4.  Back to cited text no. 12
  [Full text]  


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed782    
    Printed102    
    Emailed0    
    PDF Downloaded165    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]